Milestone Asset Management LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Milestone Asset Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,309 shares of the healthcare conglomerate’s stock after buying an additional 1,449 shares during the quarter. Milestone Asset Management LLC’s holdings in UnitedHealth Group were worth $2,743,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Eos Management L.P. raised its stake in UnitedHealth Group by 57.3% during the fourth quarter. Eos Management L.P. now owns 7,616 shares of the healthcare conglomerate’s stock worth $2,514,000 after purchasing an additional 2,773 shares during the period. Teacher Retirement System of Texas raised its position in shares of UnitedHealth Group by 11.8% during the 4th quarter. Teacher Retirement System of Texas now owns 255,768 shares of the healthcare conglomerate’s stock valued at $84,432,000 after buying an additional 27,087 shares during the period. WP Advisors LLC increased its stake in UnitedHealth Group by 2.8% during the fourth quarter. WP Advisors LLC now owns 24,233 shares of the healthcare conglomerate’s stock worth $7,999,000 after acquiring an additional 664 shares during the last quarter. Mystic Asset Management Inc. lifted its stake in shares of UnitedHealth Group by 8.1% in the 4th quarter. Mystic Asset Management Inc. now owns 6,140 shares of the healthcare conglomerate’s stock valued at $2,027,000 after purchasing an additional 458 shares during the last quarter. Finally, Schear Investment Advisers LLC increased its position in shares of UnitedHealth Group by 7.6% during the 4th quarter. Schear Investment Advisers LLC now owns 5,269 shares of the healthcare conglomerate’s stock worth $1,739,000 after purchasing an additional 370 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on UNH shares. Oppenheimer increased their target price on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Raymond James Financial raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price on the stock in a research report on Wednesday, April 1st. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a research note on Monday, February 2nd. Finally, Robert W. Baird increased their target price on UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $377.68.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and outlook raise — UNH reported stronger-than-expected Q1 results (EPS beat, $111.7B revenue) and raised 2026 adjusted EPS guidance, which investors interpreted as evidence the turnaround is underway. VIEW: UnitedHealth’s strong first quarter, forecast raise cheer Wall Street (Reuters)
• Positive Sentiment: Analyst upgrades and target hikes — Several firms (Argus, Oppenheimer, RBC, Wells Fargo, Morgan Stanley and others) raised ratings/targets after the quarter, signaling broader buy-side confidence and providing further upside signals for the stock. These Analysts Increase Their Forecasts On UnitedHealth After Upbeat Earnings (Benzinga)
• Positive Sentiment: AI and operational investments — Management announced meaningful AI spending (reported ~$1.5B) and expansion of Optum Real transaction processing, positioning Optum as a higher-throughput, margin-enhancing platform over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare (PYMNTS)
• Positive Sentiment: Bullish options flow — Unusually large call buying was recorded (roughly 164k calls), suggesting short-term investor optimism or hedging ahead of follow-through. (No direct article link available)
• Neutral Sentiment: Rural health initiative — The company launched a broad rural-health program to serve underserved communities; positive for long-term growth/PR but unlikely to move near-term earnings materially. UnitedHealth Launches Broad Rural Health Initiative (InsiderMonkey)
• Neutral Sentiment: Industry/peer lift — Strong UNH results boosted sentiment across insurers (CVS, Humana, Centene), but sector moves may contain idiosyncratic risks tied to medical-cost trends and policy. UnitedHealth Sets Sights on AI, Climbs (Yahoo Finance)
• Negative Sentiment: Policy/program uncertainty — UnitedHealth flagged challenges with a Medicare obesity-drug pilot, creating uncertainty about participation and near-term costs related to new drug coverage programs. UnitedHealth flags challenges in Medicare obesity drug pilot (Reuters)
• Negative Sentiment: Residual analyst caution — A few firms still express caution (e.g., Robert W. Baird maintains an underperform view with a lower target), reflecting lingering concerns about execution and medical-cost volatility. Analyst note listing (Benzinga)

UnitedHealth Group Stock Performance

NYSE:UNH opened at $353.51 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $438.85. The company has a fifty day simple moving average of $290.76 and a two-hundred day simple moving average of $317.09. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 26.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same period last year, the business posted $7.20 earnings per share. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 18.43 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.